These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 19064814

  • 1. Distinct roles of protease-activated receptors in signal transduction regulation of endothelial nitric oxide synthase.
    Suzuki H, Motley ED, Eguchi K, Hinoki A, Shirai H, Watts V, Stemmle LN, Fields TA, Eguchi S.
    Hypertension; 2009 Feb; 53(2):182-8. PubMed ID: 19064814
    [Abstract] [Full Text] [Related]

  • 2. Featured Article: Differential regulation of endothelial nitric oxide synthase phosphorylation by protease-activated receptors in adult human endothelial cells.
    Tillery LC, Epperson TA, Eguchi S, Motley ED.
    Exp Biol Med (Maywood); 2016 Mar; 241(6):569-80. PubMed ID: 26729042
    [Abstract] [Full Text] [Related]

  • 3. Role of protease-activated receptor-1 in endothelial nitric oxide synthase-Thr495 phosphorylation.
    Watts VL, Motley ED.
    Exp Biol Med (Maywood); 2009 Feb; 234(2):132-9. PubMed ID: 19064940
    [Abstract] [Full Text] [Related]

  • 4. Differential actions of PAR2 and PAR1 in stimulating human endothelial cell exocytosis and permeability: the role of Rho-GTPases.
    Klarenbach SW, Chipiuk A, Nelson RC, Hollenberg MD, Murray AG.
    Circ Res; 2003 Feb 21; 92(3):272-8. PubMed ID: 12595338
    [Abstract] [Full Text] [Related]

  • 5. Distinct roles for PAR1- and PAR2-mediated vasomotor modulation in human arterial and venous conduits.
    Ballerio R, Brambilla M, Colnago D, Parolari A, Agrifoglio M, Camera M, Tremoli E, Mussoni L.
    J Thromb Haemost; 2007 Jan 21; 5(1):174-80. PubMed ID: 17059415
    [Abstract] [Full Text] [Related]

  • 6. PAR1 and PAR2 couple to overlapping and distinct sets of G proteins and linked signaling pathways to differentially regulate cell physiology.
    McCoy KL, Traynelis SF, Hepler JR.
    Mol Pharmacol; 2010 Jun 21; 77(6):1005-15. PubMed ID: 20215560
    [Abstract] [Full Text] [Related]

  • 7. Modulation of Rho GTPase activity in endothelial cells by selective proteinase-activated receptor (PAR) agonists.
    Vouret-Craviari V, Grall D, Van Obberghen-Schilling E.
    J Thromb Haemost; 2003 May 21; 1(5):1103-11. PubMed ID: 12871383
    [Abstract] [Full Text] [Related]

  • 8. A role for proteinase-activated receptor 2 and PKC-epsilon in thrombin-mediated induction of decay-accelerating factor on human endothelial cells.
    Lidington EA, Steinberg R, Kinderlerer AR, Landis RC, Ohba M, Samarel A, Haskard DO, Mason JC.
    Am J Physiol Cell Physiol; 2005 Dec 21; 289(6):C1437-47. PubMed ID: 16079188
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.
    Shi X, Gangadharan B, Brass LF, Ruf W, Mueller BM.
    Mol Cancer Res; 2004 Jul 21; 2(7):395-402. PubMed ID: 15280447
    [Abstract] [Full Text] [Related]

  • 11. Proteinase-activated receptor-1 (PAR1) and PAR2 mediate relaxation of guinea pig internal anal sphincter.
    Huang SC.
    Regul Pept; 2014 Feb 10; 189():46-50. PubMed ID: 24631471
    [Abstract] [Full Text] [Related]

  • 12. Protease-activated receptor 2 (PAR2) is upregulated by Acanthamoeba plasminogen activator (aPA) and induces proinflammatory cytokine in human corneal epithelial cells.
    Tripathi T, Abdi M, Alizadeh H.
    Invest Ophthalmol Vis Sci; 2014 May 29; 55(6):3912-21. PubMed ID: 24876278
    [Abstract] [Full Text] [Related]

  • 13. Dual blockade of protease-activated receptor 1 and 2 additively ameliorates diabetic kidney disease.
    Mitsui S, Oe Y, Sekimoto A, Sato E, Hashizume Y, Yamakage S, Kumakura S, Sato H, Ito S, Takahashi N.
    Am J Physiol Renal Physiol; 2020 May 01; 318(5):F1067-F1073. PubMed ID: 32200667
    [Abstract] [Full Text] [Related]

  • 14. Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter.
    Huang SC.
    Regul Pept; 2007 Jul 05; 142(1-2):37-43. PubMed ID: 17335921
    [Abstract] [Full Text] [Related]

  • 15. Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase.
    Eto M, Barandiér C, Rathgeb L, Kozai T, Joch H, Yang Z, Lüscher TF.
    Circ Res; 2001 Sep 28; 89(7):583-90. PubMed ID: 11577023
    [Abstract] [Full Text] [Related]

  • 16. Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling.
    Riewald M, Ruf W.
    J Biol Chem; 2005 May 20; 280(20):19808-14. PubMed ID: 15769747
    [Abstract] [Full Text] [Related]

  • 17. Distinct Ca2+ requirement for NO production between proteinase-activated receptor 1 and 4 (PAR1 and PAR4) in vascular endothelial cells.
    Hirano K, Nomoto N, Hirano M, Momota F, Hanada A, Kanaide H.
    J Pharmacol Exp Ther; 2007 Aug 20; 322(2):668-77. PubMed ID: 17494865
    [Abstract] [Full Text] [Related]

  • 18. Effect of protease-activated receptor (PAR)-1, -2 and -4-activating peptides, thrombin and trypsin in rat isolated airways.
    Chow JM, Moffatt JD, Cocks TM.
    Br J Pharmacol; 2000 Dec 20; 131(8):1584-91. PubMed ID: 11139435
    [Abstract] [Full Text] [Related]

  • 19. Proteinase-activated receptors 1 and 2 exert opposite effects on renal renin release.
    Höcherl K, Gerl M, Schweda F.
    Hypertension; 2011 Oct 20; 58(4):611-8. PubMed ID: 21859963
    [Abstract] [Full Text] [Related]

  • 20. Determinants of the specificity of protease-activated receptors 1 and 2 signaling by factor Xa and thrombin.
    Rana S, Yang L, Hassanian SM, Rezaie AR.
    J Cell Biochem; 2012 Mar 20; 113(3):977-84. PubMed ID: 22034092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.